Mersana Therapeutics Inc. (MRSN)
NASDAQ: MRSN
· Real-Time Price · USD
6.82
-0.30 (-4.21%)
At close: Sep 05, 2025, 3:59 PM
6.77
-0.76%
After-hours: Sep 05, 2025, 07:48 PM EDT
Mersana Therapeutics Revenue Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 |
|---|---|---|
| Reportable Segment Revenue | 3.06M | 2.75M |
| Reportable Segment Revenue Growth | +10.97% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 7.13M | 8.93M | 8.89M | 9.86M | 10.5M | 11.14M | 9.69M | 12.89M | 18.19M | 18.33M | 14.8M | 14.57M | 14.8M | 12.78M | 10.67M | 10.12M | 8.88M | 7.21M | 5.91M | 5.88M | 5.17M | 4.94M | 4.21M | 4.44M | 4.19M | 4.44M | 4.15M | 4.38M | 4.23M | 3.57M | 3.06M | 2.9M | 2.2M | 2.3M | 1.94M | 1.6M | 1.83M | 1.62M |
| Selling, General, and Administrative Revenue Growth | -20.13% | +0.44% | -9.91% | -6.08% | -5.69% | +14.97% | -24.87% | -29.10% | -0.77% | +23.80% | +1.59% | -1.55% | +15.81% | +19.75% | +5.43% | +13.97% | +23.24% | +21.88% | +0.56% | +13.73% | +4.76% | +17.19% | -5.05% | +5.82% | -5.65% | +7.01% | -5.21% | +3.52% | +18.48% | +16.85% | +5.20% | +31.81% | -4.01% | +18.35% | +21.40% | -12.49% | +12.65% | n/a |
| Research and Development Revenue | 16.22M | 18.34M | 22.29M | 14.8M | 17.25M | 18.69M | 21.5M | 30.53M | 48.97M | 47.27M | 45.71M | 50.64M | 41.23M | 35.81M | 37.37M | 35.27M | 31.95M | 27.41M | 22.86M | 16.55M | 15.41M | 12.22M | 12.43M | 13.7M | 13.77M | 15.14M | 19.82M | 15.18M | 12.66M | 12.26M | 14.55M | 11.41M | 10.63M | 10.11M | 8.85M | 7.55M | 8.17M | 7.44M |
| Research and Development Revenue Growth | -11.58% | -17.70% | +50.55% | -14.16% | -7.71% | -13.07% | -29.60% | -37.65% | +3.58% | +3.43% | -9.74% | +22.82% | +15.15% | -4.18% | +5.93% | +10.39% | +16.56% | +19.94% | +38.14% | +7.35% | +26.14% | -1.70% | -9.28% | -0.47% | -9.09% | -23.58% | +30.54% | +19.88% | +3.32% | -15.80% | +27.54% | +7.39% | +5.16% | +14.26% | +17.07% | -7.54% | +9.88% | n/a |